ロード中...
Combining Immune Checkpoint Inhibitors with Anti-Angiogenic Agents
Immunotherapy has recently emerged as a novel strategy for treating different types of solid tumors, with promising results. However, still a large fraction of patients do not primarily respond to such approaches, and even responders sooner or later develop resistance. Moreover, immunotherapy is a p...
保存先:
| 出版年: | J Clin Med |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7141336/ https://ncbi.nlm.nih.gov/pubmed/32138216 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9030675 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|